Publikationen 2017

Verburg FA, Luster M. 
Thyroid cancer: Redifferentiation - a 'new' option for (131)I-negative DTC.
Nat Rev Endocrinol. 2016 Nov 11.
https://www.nature.com/articles/nrendo.2016.182

---

Verburg FA, Luster M. 
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1611-1613. doi: 10.1007/s00259-017-3767-4. Epub 2017 Jul 4.
https://link.springer.com/article/10.1007%2Fs00259-017-3767-4

---

Reviews 2017

Verburg FA, Hänscheid H, Luster M.
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer.
Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):279-290. doi: 10.1016/j.beem.2017.04.010. Epub 2017 May 9.
https://www.sciencedirect.com/science/article/abs/pii/S1521690X17300386?via%3Dihub

---

Luster M, Pfestroff A, Verburg FA.
Recent advances in nuclear medicine in endocrine oncology.
Curr Opin Oncol. 2017 Jan;29(1):1-6.
https://insights.ovid.com/pubmed?pmid=27906859

---

Luster M, Pfestroff A, Hänscheid H, Verburg FA.
Radioiodine Therapy.
Semin Nucl Med. 2017 Mar;47(2):126-134. doi: 10.1053/j.semnuclmed.2016.10.002. Epub 2016 Nov 1.
https://www.sciencedirect.com/science/article/pii/
S0001299816300903?via%3Dihub

---

Verburg FA, Van Santen HM, Luster M.
Pediatric papillary thyroid cancer: current management challenges.
Onco Targets Ther. 2016 Dec 28;10:165-175. doi: 10.2147/OTT.S100512. eCollection 2017.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207438/

---